54.83
0.12%
0.00
Finanzdaten der Soleno Therapeutics Inc-Aktie (SLNO)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
68.76%
23.48
|
13.91 | 10.38 | 8.623 | 8.469 |
Depreciation and Amortization |
0.20%
0.49
|
0.489 | 0.49 | 0.489 | 0.49 |
Operating Income/Loss |
68.76%
-23.48
|
-13.91 | -10.38 | -8.623 | -8.469 |
Nonoperating Income/Loss |
20.54%
2.077
|
2.614 | -0.479 | 0.148 | 0.113 |
Income/Loss From Continuing Operations Before Tax |
89.43%
-21.40
|
-11.30 | -10.86 | -8.475 | -8.356 |
Income/Loss From Continuing Operations After Tax |
89.43%
-21.40
|
-11.30 | -10.86 | -8.475 | -8.356 |
Net Income/Loss
|
89.43%
-21.40
|
-11.30 | -10.86 | -8.475 | -8.356 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
498.59%
36.21
|
6.0489 | 11.44 | 10.42 | 9.4474 |
Diluted Average Shares |
498.59%
36.21
|
6.0489 | 11.44 | 10.42 | 9.4474 |
Basic Earnings Per Share |
303.45%
-0.59
|
0.29 | -0.95 | -0.81 | -0.88 |
Diluted Earnings Per Share |
303.45%
-0.59
|
0.29 | -0.95 | -0.81 | -0.88 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):